The effect of a T cell-specific NF-κB inhibitor on in vitro cytokine production and collagen-induced arthritis

Journal of Immunology

Volumn 165, Issue 3, 2000, Pages 1652-1658

  Gerlag, Danielle M ^a   Ransone, Lynn ^b   Tak, Paul P ^a,c   Han, Zuoning ^a   Palanki, Moorthy ^b   Barbosa, Miguel S ^b   Boyle, David ^a   Manning, Anthony M ^b   Firestein, Gary S ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Signal Pharmaceuticals   (United States)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; LEUKEMIA CELL LINE; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 0034254439     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.3.1652     Document Type: Article

References (29)

1. Tak, P. P., T. J. M. Smeets, M. R. Daha, P. M. Kluin, K. A. E. Meijers, R. Brand, A. E. Meinders, and F. C. Breedveld. 1997. Analysis of the synovial cellular infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum. 40:217.
2. Firestein, G. S. 1996. Etiology and pathogenesis of rheumatoid arthritis. In Textbook of rheumatology. 5th Ed. W.N. Kelly, E.D. Harris, S. Ruddy and C.B. Sledge, eds. W.B. Saunders Co., Philadelphia, p. 851.
3. Firestein, G. S., and N. J. Zvaifler. 1990. How important are T cells in chronic rheumatoid synovitis. Arthritis Rheum. 33:768.
4. Barnes, P. J., and M. Karin. 1997. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066.
5. Handel, M. L., L. B. McMorrow, and E. M. Gravallese. 1995. Nuclear factor-κB in rheumatoid synovium: localization of p50 and p65. Arthritis Rheum. 38:1762.
6. Marok, R., P. G. Winyard, A. Coumbe, M. L. Kus, K. Gaffney, S. Blades, P. I. Mapp, C. J. Morris, D. R. Blake, C. Kaltschmidt, and P. A. Baeuerle. 1996. Activation of the transcription factor nuclear factor-κB in human inflamed synovial tissue. Arthritis Rheum. 39:583.
7. Miyazawa, K., A. Mori, K. Yamamoto, and H. Okudaira. 1998. Constitutive transcription of the human interleukin-6 gene by rheumatoid synoviocytes: Spontaneous activation of NF-κB and CBF1. Am. J. Pathol 152:793.
8. Goldman, M. E., L. J. Ransone, D. W. Anderson, W. A. Gaarde, M. J. Suto, R. W. Sullivan, R. Shorthouse, M. Morikawa, and R. E. Morris. 1996. SP100030 is a novel T-cell-specific transcription factor inhibitor that possesses immunosuppressive activity in vivo. Transplant. Proc. 28:3106.
9. Sullivan, R. W., C. G. Bigam, P. E. Erdman, M. S. Palanki, D. W. Anderson, M. E. Goldman, L. J. Ransone, and M. J. Suto. 1998. 2-Chloro-4-(trifluoromethyl)pyrimidine-5-N-(3′, 5′-bis(trifluoromethyl)phenyl)-carboxamide: a potent inhibitor of NF-κB-and AP-1-mediated gene expression identified using solution-phase combinatorial chemistry. J. Med. Chem. 41:413.
10. Han, Z. N., D. L. Boyle, A. M. Manning, and G. S. Firestein. 1998. AP-1 and NF-κB regulation in rheumatoid arthritis and mutine collagen-induced arthritis. Autoimmunity. 28:197.
11. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:6419.
12. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
13. Elliott, M. J., R. N. Maini, M. Feldmann, J. R. Kalden, C. Antoni, J. S. Smolen, B. Leeb, F. C. Breedveld, J. D. Macfarlane, H. Bijl, and J. N. Woody. 1994. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor a (cA2) versus placebo in rheumatoid arthritis. Lancet 344: 1105.
14. Moreland, L. W., S. W. Baumgartner, M. H. Schiff, E. A. Tindall, R. M. Fleischmann, A. L. Weaver, R. E. Ettlinger, S. Cohen, W. J. Koopman, K. Mohler, M. B. Widmer, and C. M. Blosch. 1997. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med. 337:141.
15. Miyazawa, K., A. Mori, and H. Okudaira. 1999. IL-6 synthesis by rheumatoid synoviocytes is autonomously upregulated at the transcriptional level. J. Allergy Clin. Immunol. 103:S437.
16. Bondeson, J., B. Foxwell, F. Brennan, and M. Feldmann. 1999. Defining therapeutic targets by using adenovirus: blocking NF-κB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators. Proc. Natl. Acad. Sci. USA 96:5668.
17. Firestein, G. S., D. L. Boyle, C. Yu, M. M. Paine, T. D. Whisenand, N. J. Zvaifler, and W. P. Arend. 1994. Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum. 37:644.
18. Dayer, J. M., and D. Burger. 1994. Interleukin-1. tumor necrosis factor and their specific inhibitors. Eur. Cytokine Netw. 5:563.
19. Shin, H., I. Kitajima, T. Nakajima, Q. Shao, T. Tokioka, I. Takasaki, N. Hanyu, T. Kubo, and I. Maruyama. 1999. Thrombin receptor mediated signals induce expressions of interleukin 6 and granulocyte colony stimulating factor via NF-κB activation in synovial fibroblasts. Ann. Rheum. Dis. 58:55.
20. Aupperle, K. R., B. L. Bennett, D. L. Boyle, P. P. Tak, A. M. Manning, and G. S. Firestein. 1999. NF-κB regulation by IκB kinase in primary fibroblast-like synoviocytes. J. Immunol. 163:427.
21. Sakurada, S., T. Kato, and T. Okamoto. 1996. Induction of cytokines and ICAM-1 by proinflammatory cytokines in primary rheumatoid synovial fibroblasts and inhibition by N-acetyl-L-cysteine and aspirin. Int. Immunol. 8:1483.
22. Vincenti, M. P., C. I. Coon, and C. E. Brinckerhoff. 1998. Nuclear factor κB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1β-stimulated synovial fibroblasts. Arthritis Rheum. 41:1987.
23. Burger, D., R. Rezzonico, J. M. Li, C. Modoux, R. A. Pierce, H. G. Welgus, and J. M. Dayer. 1998. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines. Arthritis Rheum. 41:1748.
24. Seetharaman, R., A. L. Mora, G. Nabozny, M. Boothby, and J. Chen. 1999. Essential role of T cell NF-κB activation in collagen-induced arthritis. J. Immunol. 163:1577.
25. Smeets, T. J. M., R. J. E. M. Dolhain, A. M. M. Miltenburg, R. de Kuiper, F. C. Breedveld, and P. P. Tak. 1998. Poor expression of T cell-derived cytokines and activation and proliferation markers in early rheumatoid synovial tissue. Clin. Immunol. Immunopathol. 88:84.
26. Wahl, C., S. Liptay, G. Adler, and R. M. Schmid. 1998. Sulfasalazine: a potent and specific inhibitor of nuclear factor κB. J. Clin. Invest. 101:1163.
27. Kopp, E., and S. Ghosh. 1994. Inhibition of NF-κB by sodium salicylate and aspirin. Science 265:956.
28. Barnes, P. J. 1998. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin. Sci. 94:557.
29. Miagkov, A. V., D. V. Kovalenko, C. E. Brown, J. R. Didsbury, J. P. Cogswell, S. A. Stimpson, A. S. Baldwin, and S. S. Makarov. 1998. NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc. Natl. Acad. Sci. USA 95:13859.